Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
5.90
+0.08 (1.37%)
At close: Mar 6, 2026, 4:00 PM EST
5.89
-0.01 (-0.17%)
After-hours: Mar 6, 2026, 7:42 PM EST
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $316.16 million as of March 6, 2026. Its market cap has increased by 64.38% in one year.
Market Cap
316.16M
Enterprise Value
186.19M
1-Year Change
64.38%
Ranking
Category
Stock Price
$5.90
Market Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from $173.16M to $316.16M, an increase of 82.59%. That is a compound annual growth rate of 10.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 311.88M | 9.19% |
| Dec 31, 2025 | 285.62M | 12.67% |
| Dec 31, 2024 | 253.49M | 1,089.52% |
| Dec 29, 2023 | 21.31M | -29.43% |
| Dec 30, 2022 | 30.20M | -60.18% |
| Dec 31, 2021 | 75.84M | -72.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avalo Therapeutics | 348.97M |
| Monopar Therapeutics | 346.69M |
| Relmada Therapeutics | 342.47M |
| Neurogene | 340.62M |
| Climb Bio | 338.51M |
| Foghorn Therapeutics | 323.37M |
| Sutro Biopharma | 322.84M |
| Rezolute | 320.96M |